PAPER Gropman AL, Batshaw ML
SEARCH RESULTS
330919 RESULTS
PAPER Laskowitz DT, Song P, Wang H, Mace B, Sullivan PM, Vitek MP, Dawson HN
Traumatic brain injury exacerbates neurodegenerative pathology: improvement with an apolipoprotein E-based therapeutic.
J Neurotrauma. 2010 Nov;27(11):1983-95. PubMed: 20812776PAPER Ben Fredj N, Hammond S, Otsuna H, Chien CB, Burrone J, Meyer MP
Synaptic activity and activity-dependent competition regulates axon arbor maturation, growth arrest, and territory in the retinotectal projection.
J Neurosci. 2010 Aug 11;30(32):10939-51. PubMed: 20702722PAPER Wetmore DZ, Garner CC
Emerging pharmacotherapies for neurodevelopmental disorders.
J Dev Behav Pediatr. 2010 Sep;31(7):564-81. PubMed: 20814256PAPER Kim JY, Kim DH, Kim DS, Kim JH, Jeong SY, Jeon HB, Lee EH, Yang YS, Oh W, Chang JW
Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-beta42 neurotoxicity in vitro.
FEBS Lett. 2010 Aug 20;584(16):3601-8. PubMed: 20655311PAPER
Dementia syndromes in the elderly. Alzheimer's disease is most common, but other diagnoses are possible.
Fortschr Neurol Psychiatr. 2010 Oct;78(10):582-9. PubMed: 20812411PAPER Hu LF, Lu M, Hon Wong PT, Bian JS
Hydrogen sulfide: neurophysiology and neuropathology.
Antioxid Redox Signal. 2011 Jul 15;15(2):405-19. PubMed: 20812864PAPER Nakamura T, Lipton SA
S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
Antioxid Redox Signal. 2011 Apr 15;14(8):1479-92. PubMed: 20812868PAPER Yasuda S, Sugiura H, Tanaka H, Takigami S, Yamagata K
p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases.
Cent Nerv Syst Agents Med Chem. 2011 Mar 1;11(1):45-59. PubMed: 20812905PAPER Clark IA, Alleva LM, Vissel B
The roles of TNF in brain dysfunction and disease.
Pharmacol Ther. 2010 Dec;128(3):519-48. PubMed: 20813131PAPER Song Y, Wang J
Overview of Chinese research on senile dementia in mainland China.
Ageing Res Rev. 2010 Nov;9 Suppl 1:S6-12. PubMed: 20813206PAPER Mielke MM, Haughey NJ, Ratnam Bandaru VV, Schech S, Carrick R, Carlson MC, Mori S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG
Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss.
Alzheimers Dement. 2010 Sep;6(5):378-85. PubMed: 20813340PAPER Okonkwo OC, Alosco ML, Jerskey BA, Sweet LH, Ott BR, Tremont G,
Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
Alzheimers Dement. 2010 Sep;6(5):404-11. PubMed: 20813341PAPER Whitehair DC, Sherzai A, Emond J, Raman R, Aisen PS, Petersen RC, Fleisher AS,
Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
Alzheimers Dement. 2010 Sep;6(5):412-9. PubMed: 20813342PAPER Iqbal K, Grundke-Iqbal I
Alzheimer's disease, a multifactorial disorder seeking multitherapies.
Alzheimers Dement. 2010 Sep;6(5):420-4. PubMed: 20813343Current Filters
No filters selected